The UAMS Myeloma Institute is an international leader in the treatment and study of multiple myeloma and related diseases. Our team of renowned scientists and clinicians translates advances from the laboratory into novel clinical treatments, continually expanding the boundaries of myeloma research and therapy toward cure.
The Myeloma Institute has more than 25 years of clinical and research excellence focused exclusively on multiple myeloma and related conditions, and is known worldwide for its high volume of patients and outstanding outcomes.
A type of cancer that begins in plasma cells (white blood cells that produce antibodies). A plasmacytoma may turn into multiple myeloma.
Blood cell development. A blood stem cell goes through several steps to become a red blood cell, platelet, or white blood cell.